Silence Therapeutics plc (SLN) Shareholders’ equity 2022–2025
Silence Therapeutics plc (SLN) shareholders’ equity at each fiscal year-end, per SEC filings.
$62.3MFY2025 · since FY2022: $27.2M → $62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $62.3M | -53.5% |
| FY2024 | $134.0M | +509.4% |
| FY2023 | $22.0M | -19.2% |
| FY2022 | $27.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice